Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBT-1 Phase 1b in Healthy Volunteers and CKD
NCT03893799Phase 1Completed
- Sponsor
- Renibus Therapeutics
- Start
- Aug 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of stannic protoporfin + iron sucrose in acute kidney injury (AKI) (5 arms), sponsored by Renibus Therapeutics. Primary endpoints: Plasma Ferritin Levels, Plasma Heme Oxygenase-1 Levels and 1 more. Started Aug 2019; status: completed.
02
Drugs
stannic protoporfin + iron sucrose
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03893799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893799.